TH2 cytokine expression in atopic children with otitis media with effusion

Journal of Allergy and Clinical Immunology

Volumn 110, Issue 1, 2002, Pages 125-130

  Sobol, Steven E ^a,b   Taha, Rame ^b   Schloss, Melvin D ^a   Mazer, Bruce D ^a   Manoukian, John J ^a   Tewfik, Ted L ^a   Hamid, Qutayba ^b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Allergies; Atopy; Children; Cytokines; Effusion; Otitis media

Indexed keywords

CD3 ANTIGEN; CYTOKINE; ELASTASE; GAMMA INTERFERON; INTERLEUKIN 4; INTERLEUKIN 5; MAJOR BASIC PROTEIN; PROTEIN; TRYPTASE;

ARTICLE; ATOPY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; EOSINOPHIL; HUMAN; IMMUNOCYTOCHEMISTRY; IN SITU HYBRIDIZATION; INFLAMMATORY CELL; INTERFERON PRODUCTION; MYRINGOTOMY; NEUTROPHIL; PRIORITY JOURNAL; SECRETORY OTITIS MEDIA; SKIN TEST; T LYMPHOCYTE; TH2 CELL; TUBE; UNIVERSITY HOSPITAL;

EID: 0036971280     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2002.125697     Document Type: Article

References (44)

1. Zielhuis GA, Rach GH, van den Broek P. Predisposing factors for otitis media with effusion in young children. Adv Otorhinolaryngol 1988;40:65-9.
2. Cypress BK. Patterns of ambulatory care in pediatrics: the National Ambulatory Medical Care Survey. Vital Health Slat 13 1983;75:1-60.
3. Teele DW, Klein JO, Rosner BA. Otitis media with effusion during the first three years of life and development of speech and language. Pediatrics 1984;74:282-7.
4. Paradise JL, Feldman HM, Campbell TF, et al. Effect of early or delayed insertion of tympanostomy tubes for persistent otitis media on developmental outcomes at the age of three years. N Engl J Med 2001;344:1179-87.
5. Watson P, Voss L, Barber C, Aickin R, Bremner D, Lennon D. The microbiology of chronic otitis media with effusion in a group of Auckland children. N Z Med J 1996;109:182-4.
6. Teele DW, Pelton SI, Klein JO. Bacteriology of acute otitis media unresponsive to initial antimicrobial therapy. J Pediatr 1981;98:537-9.
7. Williams RL, Chalmers TC, Stange KC, Chalmers FT, Bowlin SJ. Use of antibiotics in preventing recurrent acute otitis media and in treating otitis media with effusion. A meta-analytic attempt to resolve the brouhaha. JAMA 1993;270:1344-51.
8. Alho OP, Oja H, Koivu M, Sorri M. Chronic otitis media with effusion in infancy. How frequent is it? How does it develop? Arch Otolaryngol Head Neck Surg 1995;121:432-6.
9. Shaw CB, Obermyer N, Wetmore SJ, Spirou GA, Farr RW. Incidence of adenovirus and respiratory syncytial virus in chronic otitis media with effusion using the polymerase chain reaction. Otolaryngol Head Neck Surg 1995;113:234-41.
10. Robinson DS, Hamid Q, Ying S, et al. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992;326:298-304.
11. Durham SR, Ying S, Varney VA, et al. Cytokine messenger RNA expression for IL-3, IL-4, IL-5, and granulocyte/macrophage-colony-stimulating factor in the nasal mucosa after local allergen provocation: relationship to tissue eosinophilia. J Immunol 1992;148:2390-4.
12. Hamilos DL, Leung DY, Wood R, et al. Evidence for distinct cytokine expression in allergic versus nonallergic chronic sinusitis. J Allergy Clin Immunol 1995;96:537-44.
13. Frew AJ, Kay AB. The relationship between infiltrating CD4+ lymphocytes, activated eosinophils, and the magnitude of the allergen-induced late phase cutaneous reaction in man. J Immunol 1988;141:4158-64.
14. Hamid Q, Wharton J, Terenghi G, et al. Localization of atrial natriuretic peptide mRNA and immunoreactivity in the rat heart and human atrial appendage. Proc Natl Acad Sci U S A 1987;84:6760-4.
15. McMahan JT, Calenoff E, Croft DJ, Barenholtz L, Weber LD. Chronic otitis media with effusion and allergy: modified RAST analysis of 119 cases. Otolaryngol Head Neck Surg 1981;89:427-31.
16. Bernstein JM. The role of IgE-mediated hypersensitivity in the development of otitis media with effusion: a review. Otolaryngol Head Neck Surg 1993;109:611-20.
17. Mogi G, Tomonaga K, Watanabe T, Chaen T. The role of type I allergy in secretory otitis media and mast cells in the middle ear mucosa. Acta Otolaryngol Suppl 1992;493:155-63.
18. Ackerman MN, Friedman RA, Doyle WJ, Bluestone CD, Fireman R. Antigen-induced eustachian tube obstruction: an intranasal provocative challenge test. J Allergy Clin Immunol 1984;73:604-9.
19. Fireman P. Nasal provocation testing: an objective assessment for nasal and eustachian tube obstruction. J Allergy Clin Immunol 1988;81:953-60.
20. Ojala K, Sipila P, Sorri M, Karma P. Role of atopic allergy in chronic otitis media. Evaluation based on serum IgE and nasal/aural cytologic findings in patients with operated chronic ears. Acta Otolaryngol 1982;93:55-60.
21. Kraemer MJ, Richardson MA, Weiss NS, et al. Risk factors for persistent middle-ear effusions. Otitis media, catarrh, cigarette smoke exposure, and atopy. JAMA 1983;249:1022-5.
22. Tainio VM, Savilahti E, Salmenpera L, Arjomaa P, Slimes MA, Perheentupa J. Risk factors for infantile recurrent otitis media: atopy but not type of feeding. Pediatr Res 1988;23:509-12.
23. Caffarelli C, Savini E, Giordano S, Gianlupi G, Cavagni G. Atopy in children with otitis media with effusion. Clin Exp Allergy 1998;28:591-6.
24. Kvaerner KJ, Tambs K, Harris JR, Mair IW, Magnus P. Otitis media: relationship to tonsillitis, sinusitis and atopic diseases. Int J Pediatr Otorhinolaryngol 1996;35:127-41.
25. Sipila M, Karma P, Pukander J, Timonen M, Kataja M. The Bayesian approach to the evaluation of risk factors in acute and recurrent acute otitis media. Acta Otolaryngol 1988;106:94-101.
26. Harlin SL, Ansel DG, Lane SR, Myers J, Kephart GM, Gleich GJ. A clinical and pathologic study of chronic sinusitis: the role of the eosinophil. J Allergy Clin Immunol 1988;81:867-75.
27. Hisamatsu K, Ganbo T, Nakazawa T, et al. Cytotoxicity of human eosinophil granule major basic protein to human nasal sinus mucosa in vitro. J Allergy Clin Immunol 1990;86:52-63.
28. Holgate ST, Bradding P, Sampson AP. Leukotriene antagonists and synthesis inhibitors: new directions in asthma therapy. J Allergy Clin Immunol 1996;98:1-13.
29. Moy JN, Gleich GJ, Thomas LL. Noncytotoxic activation of neutrophils by eosinophil granule major basic protein. Effect on superoxide anion generation and lysosomal enzyme release. J Immunol 1990;145:2626-32.
30. Oddera S, Silvestri M, Balbo A, et al. Airway eosinophilic inflammation, epithelial damage, and bronchial hyperresponsiveness in patients with mild-moderate, stable asthma. Allergy 1996;51:100-7.
31. Iliopoulos O, Baroody FM, Naclerio RM, Bochner BS, Kagey-Sobotka A, Lichtenstein LM. Histamine-containing cells obtained from the nose hours after antigen challenge have functional and phenotypic characteristics of basophils. J Immunol 1992;148:2223-8.
32. Bascom R, Wachs M, Naclerio RM, Pipkom U, Galli SJ, Lichtenstein LM. Basophil influx occurs after nasal antigen challenge: effects of topical corticosteroid pretreatment. J Allergy Clin Immunol 1988;81:580-9.
33. Naclerio RM, Baroody FM, Kagey-Sobotka A, Lichtenstein LM. Basophils and eosinophils in allergic rhinitis. J Allergy Clin Immunol 1994;94:1303-9.
34. Kotsimbos AT, Hamid Q. IL-5 and IL-5 receptor in asthma. Mem Inst Oswaldo Cruz 1997;92(suppl 2):75-91.
35. Christodoulopoulos P, Cameron L, Durham S, Hamid Q. Molecular pathology of allergic disease. II: upper airway disease. J Allergy Clin Immunol 2000;105:211-23.
36. Wenzel SE, Szefler SJ, Leung DY, Sloan SI, Rex MD, Martin RJ. Bronchoscopic evaluation of severe asthma. Persistent inflammation associated with high dose glucocorticoids. Am J Respir Crit Care Med 1997;156:737-43.
37. Ondrey FG, Juhn SK, Adams GL. Early-response cytokine expression in adult middle ear effusions. Otolaryngol Head Neck Surg 1998;119:342-5.
38. Nassif PS, Simpson SQ, Izzo AA, Nicklaus PJ. Epidermal growth factor and transforming growth factor-alpha in middle ear effusion. Otolaryngol Head Neck Surg 1998;119:564-8.
39. Mogi G, Suzuki M. The role of IgE-mediated immunity in otitis media: fact or fiction? Ann N Y Acad Sci 1997;830:61-9.
40. Bikhazi P, Ryan AF. Expression of immunoregulatory cytokines during acute and chronic middle ear immune response. Laryngoscope 1995:105:629-34.
41. Hurst DS, Amin K, Seveus L, Venge P. Evidence of mast cell activity in the middle ears of children with otitis media with effusion. Laryngoscope 1999;109:471-7.
42. Hurst DS, Venge P. The presence of eosinophil cationic protein in middle ear effusion. Otolaryngol Head Neck Surg 1993;108:711-22.
43. Wright ED, Hurst DS, Miotto D, Giguere C, Hamid Q. Increased expression of major basic protein (MBP) and interleukin-5(IL-5) in middle ear biopsy specimens from atopic patients with persistent OME. Otolaryngol Head Neck Surg 2000;123:533-8.
44. Hurst DS, Venge P. Evidence of eosinophil, neutrophil, and mast-cell mediators in the effusion of OME patients with and without atopy. Allergy 2000;55:435-41.